2026 Q3 - tulosraportti
37 päivää sitten
‧59 min
2,32 USD/osake
Irtoamispäivä 7.12.
2,32%Tuotto/v
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä |
|---|---|---|
| - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Rahastoja ja ETF:iä jotka omistavat osaketta
Tuotteita joiden kohde-etuutena tämä arvopaperi
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q4 - tulosraportti 26.1.2027 |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q3 - tulosraportti 13.10. | ||
2026 Q2 - tulosraportti 16.7. | ||
Vuosittainen yhtiökokous 2026 1.6. | ||
2026 Q1 - tulosraportti 21.4. | ||
2025 Q4 - tulosraportti 27.1. |
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
- ·1 t sitten · MuokattuJust a series of comments. 1: Share-Buy back expanded November 3. It can improve EPS long-term and it may be in the company's interest to buy cheap shares (which then reduces the supply of shares). 2: In January this year CMS came with a proposal for an increase of 0.03percent for medicareaid. Then the stock dropped 20percent, but corrected months after after the proposal became approx. 3percent. By comparison with now CMS comes with a bill, but now it just needs to be negotiated finished. We must not underestimate lobbying... 3: Stephen Hemsley has an enormously great track record. There are large insider purchases and many in management who sit on many shares. There has not been noteworthy stock sales from insiders. They see the stock as cheap. Conversely by comparison Henrik Poulsen in Ørsted, who managed to sell Ørsted shares at barely 1000kr and Mike Doustar sold Novo shares at 850-880kr. For me insider selling means a lot, and that has not happened here. 4: People mention Trump in the thread further down, but he has not refrained from buying Unitedhealth shares where they last were on sale. That can be a certain reassurance. 5: Dividend percentage is high. Next when increases the dividend for 18 years in a row. 6: I am myself surprised by this drop. I must honestly admit that. Conversely if a (larger) AI stock crisis comes, then Unitedhealth is a defensive stock. Unitedhealth has a principle of 2:1 on AI. When they have spent 1kr on AI, then they must have saved 2kr. 7: If as a Dane one feels a bit stepped on by USA in connection with Greenland, then I find a little comfort in supporting Unitedhealth. Do not underestimate corporate greed in USA......
- 4 t sittenI find it interesting that people have thought this a safe investment, when this is everything but. UNH has always had a huge risk of US regulatory changes - especially on Trumps watch - and downright demands from very high level to break it to pieces. I initiated position when it basically collapsed in 2025 (from $600->$230 in a few months) and something similar is happening now. I'm seriously considering opting out while still ahead.Uh okay sir. So purely practically speaking who should step in instead? Do you expect the US to get a welfare state with a publicly funded healthcare system? Look at their budget deficit. Probably not. You are welcome to write the time horizon for your (doomsday) prophecy for the shareholders? There are large fluctuations in the market, but there are so many places. Just look at McDonald's high and low price the past 52 weeks. And Americans who go to McD don't they need health insurance!?
- ·2 päivää sittenAnyone know why this is down so much today? (The entire healthcare sector in general)
- ·15.11.Will UnitedHealth be in danger if the Democrats try to introduce health insurance reforms? Maybe it is time to sell before the ship sinks?
- ·16.10.Is this a good entry? 5-10 year horizon Vægter mellem UHC og Cigma.5-10 years ? I am quite convinced of that , if you are hesitating why not buy a little of both e.g. 60/40 in UHC favor 😉 One senses the rotation that is quietly taking place towards value, among other things towards health , so if otherwise a bit cautiously, possibly divided into 3 and on red days, I would think that it should be a good place to be.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Välittäjätilasto
Dataa ei löytynyt
2026 Q3 - tulosraportti
37 päivää sitten
‧59 min
2,32 USD/osake
Irtoamispäivä 7.12.
2,32%Tuotto/v
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
- ·1 t sitten · MuokattuJust a series of comments. 1: Share-Buy back expanded November 3. It can improve EPS long-term and it may be in the company's interest to buy cheap shares (which then reduces the supply of shares). 2: In January this year CMS came with a proposal for an increase of 0.03percent for medicareaid. Then the stock dropped 20percent, but corrected months after after the proposal became approx. 3percent. By comparison with now CMS comes with a bill, but now it just needs to be negotiated finished. We must not underestimate lobbying... 3: Stephen Hemsley has an enormously great track record. There are large insider purchases and many in management who sit on many shares. There has not been noteworthy stock sales from insiders. They see the stock as cheap. Conversely by comparison Henrik Poulsen in Ørsted, who managed to sell Ørsted shares at barely 1000kr and Mike Doustar sold Novo shares at 850-880kr. For me insider selling means a lot, and that has not happened here. 4: People mention Trump in the thread further down, but he has not refrained from buying Unitedhealth shares where they last were on sale. That can be a certain reassurance. 5: Dividend percentage is high. Next when increases the dividend for 18 years in a row. 6: I am myself surprised by this drop. I must honestly admit that. Conversely if a (larger) AI stock crisis comes, then Unitedhealth is a defensive stock. Unitedhealth has a principle of 2:1 on AI. When they have spent 1kr on AI, then they must have saved 2kr. 7: If as a Dane one feels a bit stepped on by USA in connection with Greenland, then I find a little comfort in supporting Unitedhealth. Do not underestimate corporate greed in USA......
- 4 t sittenI find it interesting that people have thought this a safe investment, when this is everything but. UNH has always had a huge risk of US regulatory changes - especially on Trumps watch - and downright demands from very high level to break it to pieces. I initiated position when it basically collapsed in 2025 (from $600->$230 in a few months) and something similar is happening now. I'm seriously considering opting out while still ahead.Uh okay sir. So purely practically speaking who should step in instead? Do you expect the US to get a welfare state with a publicly funded healthcare system? Look at their budget deficit. Probably not. You are welcome to write the time horizon for your (doomsday) prophecy for the shareholders? There are large fluctuations in the market, but there are so many places. Just look at McDonald's high and low price the past 52 weeks. And Americans who go to McD don't they need health insurance!?
- ·2 päivää sittenAnyone know why this is down so much today? (The entire healthcare sector in general)
- ·15.11.Will UnitedHealth be in danger if the Democrats try to introduce health insurance reforms? Maybe it is time to sell before the ship sinks?
- ·16.10.Is this a good entry? 5-10 year horizon Vægter mellem UHC og Cigma.5-10 years ? I am quite convinced of that , if you are hesitating why not buy a little of both e.g. 60/40 in UHC favor 😉 One senses the rotation that is quietly taking place towards value, among other things towards health , so if otherwise a bit cautiously, possibly divided into 3 and on red days, I would think that it should be a good place to be.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä |
|---|---|---|
| - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Rahastoja ja ETF:iä jotka omistavat osaketta
Tuotteita joiden kohde-etuutena tämä arvopaperi
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q4 - tulosraportti 26.1.2027 |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q3 - tulosraportti 13.10. | ||
2026 Q2 - tulosraportti 16.7. | ||
Vuosittainen yhtiökokous 2026 1.6. | ||
2026 Q1 - tulosraportti 21.4. | ||
2025 Q4 - tulosraportti 27.1. |
Välittäjätilasto
Dataa ei löytynyt
2026 Q3 - tulosraportti
37 päivää sitten
‧59 min
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q4 - tulosraportti 26.1.2027 |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q3 - tulosraportti 13.10. | ||
2026 Q2 - tulosraportti 16.7. | ||
Vuosittainen yhtiökokous 2026 1.6. | ||
2026 Q1 - tulosraportti 21.4. | ||
2025 Q4 - tulosraportti 27.1. |
2,32 USD/osake
Irtoamispäivä 7.12.
2,32%Tuotto/v
Foorumi
Liity keskusteluun Nordnet Socialissa
- ·1 t sitten · MuokattuJust a series of comments. 1: Share-Buy back expanded November 3. It can improve EPS long-term and it may be in the company's interest to buy cheap shares (which then reduces the supply of shares). 2: In January this year CMS came with a proposal for an increase of 0.03percent for medicareaid. Then the stock dropped 20percent, but corrected months after after the proposal became approx. 3percent. By comparison with now CMS comes with a bill, but now it just needs to be negotiated finished. We must not underestimate lobbying... 3: Stephen Hemsley has an enormously great track record. There are large insider purchases and many in management who sit on many shares. There has not been noteworthy stock sales from insiders. They see the stock as cheap. Conversely by comparison Henrik Poulsen in Ørsted, who managed to sell Ørsted shares at barely 1000kr and Mike Doustar sold Novo shares at 850-880kr. For me insider selling means a lot, and that has not happened here. 4: People mention Trump in the thread further down, but he has not refrained from buying Unitedhealth shares where they last were on sale. That can be a certain reassurance. 5: Dividend percentage is high. Next when increases the dividend for 18 years in a row. 6: I am myself surprised by this drop. I must honestly admit that. Conversely if a (larger) AI stock crisis comes, then Unitedhealth is a defensive stock. Unitedhealth has a principle of 2:1 on AI. When they have spent 1kr on AI, then they must have saved 2kr. 7: If as a Dane one feels a bit stepped on by USA in connection with Greenland, then I find a little comfort in supporting Unitedhealth. Do not underestimate corporate greed in USA......
- 4 t sittenI find it interesting that people have thought this a safe investment, when this is everything but. UNH has always had a huge risk of US regulatory changes - especially on Trumps watch - and downright demands from very high level to break it to pieces. I initiated position when it basically collapsed in 2025 (from $600->$230 in a few months) and something similar is happening now. I'm seriously considering opting out while still ahead.Uh okay sir. So purely practically speaking who should step in instead? Do you expect the US to get a welfare state with a publicly funded healthcare system? Look at their budget deficit. Probably not. You are welcome to write the time horizon for your (doomsday) prophecy for the shareholders? There are large fluctuations in the market, but there are so many places. Just look at McDonald's high and low price the past 52 weeks. And Americans who go to McD don't they need health insurance!?
- ·2 päivää sittenAnyone know why this is down so much today? (The entire healthcare sector in general)
- ·15.11.Will UnitedHealth be in danger if the Democrats try to introduce health insurance reforms? Maybe it is time to sell before the ship sinks?
- ·16.10.Is this a good entry? 5-10 year horizon Vægter mellem UHC og Cigma.5-10 years ? I am quite convinced of that , if you are hesitating why not buy a little of both e.g. 60/40 in UHC favor 😉 One senses the rotation that is quietly taking place towards value, among other things towards health , so if otherwise a bit cautiously, possibly divided into 3 and on red days, I would think that it should be a good place to be.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä |
|---|---|---|
| - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Rahastoja ja ETF:iä jotka omistavat osaketta
Tuotteita joiden kohde-etuutena tämä arvopaperi
Välittäjätilasto
Dataa ei löytynyt











